Hepatitis A vaccine should receive priority in National Immunization Schedule in India

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Human Vaccines & Immunotherapeutics

• Publication date

  2012-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4161/hv.20475PMID 22854671PMCID PMC3551887
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IAP Guide Book on Immunization

  2011cited by this paper
• Molecular characterization of hepatitis A virus from a large outbreak from Kerala, India.

  2006cited by this paper
• Increasing trend of acute hepatitis A in north India: Need for identification of high‐risk population for vaccination

  2006cited by this paper
• Prevalence of antibodies to hepatitis A and hepatitis E virus in urban school children in Chennai.

  2003cited by this paper
• Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence.

  2001cited by this paper
• Changing epidemiology of hepatitis A and hepatitis E in urban and rural India (1982–98)

  2001cited by this paper
• Seroepidemiology of hepatitis A infection in India: changing pattern.

  2001influential reference
• Inactivated hepatitis A vaccine‐induced antibodies: Follow‐up and estimates of long‐term persistence

  2001cited by this paper
• What did we learn from the Shanghai hepatitis A epidemic?

  2000cited by this paper
• Prevalence of hepatitis a antibodies in western Indian population: changing pattern.

  1999cited by this paper
• Seroprevalence of antibodies to hepatitis A virus among children in Northern India.

  1999cited by this paper
• Seroprevalence of hepatitis A virus in Mumbai, and immunogenicity and safety of hepatitis A vaccine.

  1998cited by this paper
• Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992.

  1995influential reference
• Epidemiological patterns of hepatitis A in different parts of the world.

  1992cited by this paper
• The declining transmission of hepatitis A in Thailand.

  1991cited by this paper
• Changing seroepidemiology of hepatitis A virus infection in Taiwan

  1985cited by this paper

• Global burden and trends of viral hepatitis among women of childbearing age from 1990 to 2021

  2025cites this paper
• Seroprevalence of Hepatitis A in Non-vaccinated Adolescents Aged 9 to 12 Years in New Delhi, India: A Cross-Sectional Study

  2025cites this paper
• Deterministic and stochastic analysis of Hepatitis A virus transmission considering vaccinated population

  2025cites this paper
• Children With Hepatitis in a Tertiary Care Center in Nepal: A Prospective Observational Study

  2024cites this paper
• Vaccination in pregnancy

  2024cites this paper
• Immunogenicity and safety of HavisureTM vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study.

  2023cites this paper
• Expression and Evaluation of a Novel HAV-VP1 and HBS-Ag Fusion Protein for Potential Applications in Immunization and Diagnosis

  2023cites this paper
• Age Group-Specific Assessment of Changing Seroepidemiology of Hepatitis A Virus Infection in North India

  2022cites this paper
• The Clinical Profile of Children With Hepatitis A Infection: An Observational Hospital-Based Study

  2022cites this paper
• Oligomers of hepatitis A virus (HAV) capsid protein VP1 generated in a heterologous expression system

  2022influential citation
• Safety and immunogenicity of inactivated hepatitis-A vaccine developed by Human Biologicals Institute in two age groups of healthy subjects: A phase I open label study.

  2021cites this paper
• A single blind randomized phase 3 study to evaluate safety and immunogenicity of inactivated hepatitis A vaccine (HAPIBEVTM) in 1-15 years-old healthy hepatitis A vaccine-naïve children.

  2021cites this paper
• Investigation of Hepatitis A virus outbreak in Aligarh and its peripheral areas, Uttar Pradesh, India

  2020cites this paper
• Prognostic, clinical, and therapeutic importance of RANTES‐CCR5 axis in hepatitis A infection: A multiapproach study

  2020cites this paper
• Need for hepatitis A prevention in patients with chronic liver disease in the changing epidemiological setting of India

  2020cites this paper
• Limited Awareness of Hepatitis B Adult Vaccination among Patients in a South Indian Teaching Hospital

  2020cites this paper
• Immunisation in children with cancer treated with standard dose chemotherapy- review of evidence

  2020cites this paper
• Increasing Burden of Hepatitis A in Adolescents and Adults and the Need for Long-Term Protection: A Review from the Indian Subcontinent

  2019cites this paper
• A study of hepatitis A virus seropositivity among children aged between 1 and 5 years of age: Implications for universal immunization.

  2019cites this paper
• Epidemiology of Hepatitis A: Past and Current Trends

  2019cites this paper
• Immunization of Children with Cancer in India Treated with Chemotherapy — Consensus Guideline from the Pediatric Hematology-Oncology Chapter and the Advisory Committee on Vaccination and Immunization Practices of the Indian Academy of Pediatrics

  2019cites this paper
• Fecal–oral-transmitted hepatitis A and E prevalence in Eastern India: A 3-year retrospective study

  2019cites this paper
• Evidence of hepatitis A virus infection in the patients with acute encephalitis syndrome in Gorakhpur region, North India.

  2018cites this paper
• Hepatitis A seroprevalence in South Africa: Are we in epidemiological transition?

  2018cites this paper
• Investigation of Hepatitis A outbreak in Palakkad district

  2017cites this paper
• Persistence of seropositivity among persons vaccinated for hepatitis A during infancy by maternal antibody status: 15‐year follow‐up

  2016cites this paper
• Comparison of immune persistence among inactivated and live attenuated hepatitis a vaccines 2 years after a single dose

  2016cites this paper
• Combating the wrath of viral hepatitis in India

  2016cites this paper
• An outbreak of hepatitis A virus among children in a flood rescue camp: A post-disaster catastrophe

  2016cites this paper
• Viral hepatitis: Indian scenario.

  2016cites this paper
• Serological and molecular epidemiology flaviviruses in selected provinces of Zambia

  2016influential citation
• Vaccination during pregnancy: Today's need in India

  2016cites this paper
• Hepatitis A virus age‐specific sero‐prevalence and risk factors among Jordanian children

  2015cites this paper
• Immunogenicity and safety of a pediatric dose of a virosomal hepatitis A vaccine in healthy children in India

  2014cites this paper
• Changing epidemiology of hepatitis A virus in Indian children

  2014cites this paper
• Exploring the concurrent presence of hepatitis A virus genome in serum, stool, saliva, and urine samples of hepatitis A patients.

  2014cites this paper
• Serum hepatitis a antibody positivity correlates with higher pancreas cancer mortality in adults: implications for hepatitis vaccination in high risk areas.

  2013cites this paper
• Assessment of immune responses to hepatitis A vaccination in children aged 1 and 2 years

  2013cites this paper
• Prevention of influenza in healthy children

  2012cites this paper